Home Share Prices Stock Picker Financial Diary UK Indices UK Industry Sectors Company Lookup Share Risers Share Fallers Broker Ratings Finance Glossary SMS Services

Share Chat Finance News Blogs Live Prices Shares Bookshop Finance Tools Members

Round table discussion - PRECIOUS METALS

Latest Share Chat

FRR. Good post reco-
mmended. The apt wo..

SOLG. Without doubt
the most clueless ..

BRDY. my damn typos....

SXX. No geological
location can possib..

SOLG. Let's say SOL
hit the big time w..

GKP. Thats always b-
een a billion dolla..

CZA. Good to see yo-
u around again bud...

SOLG. The history l-
sson from the 19:40..

BG.. Me too...Lol -
I hope our choice ..

BRDY. it's actually-
jem and i am a blok..

Ekf Diagnostics Regulatory News (EKF)

Regulatory News for Ekf Diagnostics (EKF)

Share Price: 29.50

Bid: 28.00

Ask: 31.00

Change: 0.00 (0.00%)

Spread: 3.00

Spread as %: 10.71%

Open: 29.50

High: 30.75

Low: 28.15

Yesterday’s Close: 29.50

EKF Share News

EKF ShareCast

EKF Regulatory

Holding(s) in Company

Mon, 24th Oct 2011 17:51

RNS Number : 7512Q

EKF Diagnostics Holdings PLC

24 October 2011

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ⁱⁱ

EKF Diagnostics Holdings PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the
notification obligation: ⁱⁱⁱ

BlackRock, Inc.

4. Full name of shareholder(s)
(if different from 3.):^iv

5. Date of the transaction and date on
which the threshold is crossed or
reached: ^v

20^th October 2011

6. Date on which issuer notified:

21^st October 2011

7. Threshold(s) that is/are crossed or
reached: ^{vi, vii}

Holding has gone above 5%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

GB0031509804

N/A

12,065,651

N/A

4.80%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

CFD

983,049

Nominal

CFD

0.39%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

13,048,700

5.19%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi
BlackRock Investment Management (UK) Limited - 13,048,700 (5.19%)

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	BlackRock International Threshold Reporting Team
14. Contact name:	Andrew Manchester
15. Contact telephone number:	020 7743 5773

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	BlackRock, Inc.
Contact address (registered office for legal entities)	12 Throgmorton Avenue, London, EC2N 2DL
Phone number & email	020 7743 5773; andrew.manchester@blackrock.com
Other useful information (at least legal representative for legal persons)	Andrew Manchester

B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUSSNRABARUAA

Related Shares: EKF Diagnostics Holdings (EKF).

Date	Source	Headline	Category
15-May-13 16:34	RNS	Result of AGM	Results and Trading Reports
15-May-13 07:00	RNS	AGM Statement	Results and Trading Reports
13-May-13 07:00	RNS	First PointMan DNA enrichment products launched	Company Announcement - General
15-Apr-13 13:34	RNS	Publication of Annual Report & Notice of AGM	Results and Trading Reports
18-Mar-13 07:00	RNS	Final Results	Results and Trading Reports
04-Mar-13 07:00	RNS	Establishment of EKF Molecular & Acquisition	Mergers, Acquisitions and Disposals
18-Jan-13 07:00	RNS	Pre-close Trading Update	Results and Trading Reports
21-Dec-12 15:53	RNS	Directors' Exercise of Options	Company Announcement - General
17-Dec-12 07:00	RNS	Holding(s) in Company	Holding(s) in Company
27-Nov-12 16:32	RNS	Holding(s) in Company	Holding(s) in Company
09-Nov-12 07:00	RNS	Issue of Equity	Company Announcement - General
24-Sep-12 07:00	RNS	Half Yearly Report	Results and Trading Reports
05-Sep-12 07:00	RNS	Trading Update	Company Announcement - General
14-Aug-12 07:00	RNS	NICE guidance on type 2 diabetes	Company Announcement - General
10-Aug-12 07:00	RNS	HemoCue settlement agreement	Company Announcement - General
17-Jul-12 07:00	RNS	Licensing agreement for kidney markers	Company Announcement - General
16-Jul-12 15:05	RNS	Holding(s) in Company	Holding(s) in Company
16-Jul-12 07:00	RNS	Quo-Lab CE marking & Commercial launch	Company Announcement - General
12-Jul-12 13:11	RNS	Holding(s) in Company	Holding(s) in Company
28-Jun-12 07:00	RNS	Director's Share Options	Directors' Dealings
26-Jun-12 10:30	RNS	Holding(s) in Company	Holding(s) in Company
23-May-12 13:00	RNS	Result of AGM	Results and Trading Reports
11-May-12 07:00	RNS	Update on Disposal of IBL AG	Mergers, Acquisitions and Disposals
20-Apr-12 11:18	RNS	Publication of Annual Report & Notice of AGM	Company Announcement - General
18-Apr-12 16:50	RNS	Holding(s) in Company	Holding(s) in Company
05-Apr-12 07:00	RNS	Directors' Exercise of Options	Directors' Dealings
05-Apr-12 07:00	RNS	China Patent Grant	Company Announcement - General
03-Apr-12 13:47	RNS	Holding(s) in Company	Holding(s) in Company
27-Mar-12 07:00	RNS	Disposal of International Brand Licensing AG	Mergers, Acquisitions and Disposals
26-Mar-12 08:18	RNS	Adviser Change of Name	Company Announcement - General

Regulatory news is displayed end of day, each day at 19:00.

Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.